Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BCBS New Mexico | Certolizumab Pegol | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Cerliponase alfa | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Category III Current Procedural Terminology (CPT) Codes | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Cardiac Rehabilitation in the Outpatient Setting | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Cardiac Contractility Modulation Device | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Cardiac Applications of Positron Emission Tomography Scanning | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Canakinumab | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Burosumab-twza | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bronchial Valves | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bronchial Thermoplasty | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Brolucizumab-dbll | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Botulinum Toxin | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bone Morphogenetic Protein | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Blepharoplasty and Blepharoptosis | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bioimpedance Devices for Detection and Management of Lymphedema | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biofeedback for Miscellaneous Indications | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biofeedback as a Treatment of Urinary Incontinence | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biofeedback as a Treatment of Headache | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biofeedback as a Treatment of Fecal Incontinence or Constipation | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Biofeedback as a Treatment of Chronic Pain | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bioengineered Skin and Soft Tissue Substitutes | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Benralizumab | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Belimumab | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Belatacept | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Baroreflex Stimulation Devices | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Bariatric Surgery | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Balloon Ostial Dilation for Treatment of Chronic and Recurrent Acute Rhinosinusitis | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Balloon Dilation of the Eustachian Tube | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Axillary Reverse Mapping for Prevention of Breast Cancer- Related Lymphedema | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Axial Lumbosacral Interbody Fusion | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Avacincaptad pegol | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Autonomic Nervous System (ANS) Testing | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Automated Percutaneous Discectomy and Percutaneous Endoscopic Discectomy | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Autologous Chondrocyte Implantation (ACI) for Focal Articular Cartilage Lesions | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Auditory Brainstem Implant | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Artificial Intervertebral Disc | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Aqueous Shunts and Stents for Glaucoma | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Antineoplaston Cancer Therapy | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Antigen Leukocyte Antibody Test | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Annulus Closure After Discectomy | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Anifrolumab-fnia | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Amniotic Membrane and Amniotic Fluid | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Ambulance and Transport Services | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Allograft Injection for Degenerative Disc Disease | Criteria changed |
| May 17, 2026 | BCBS New Mexico | Allogeneic Pancreas Transplant | Criteria changed |